期刊文献+

FUDR对鼻咽癌CNE-1细胞系的放射增敏作用 被引量:1

Radiosensitization by Fluorodeoxyuridine in Human Nasopharyngeal Carcinoma Cell Line CNE-1
下载PDF
导出
摘要 目的研究氟尿嘧啶脱氧核苷(FUDR)对鼻咽癌细胞系CNE-1的细胞毒性作用及联合放疗的放射增敏作用,同时和5-氟尿嘧啶(5-Fu)作比较。方法应用CCK-8法分析FUDR及5-Fu对鼻咽癌细胞的毒性作用,绘制药物的浓度抑制率曲线。通过成克隆分析法研究低浓度的FUDR及5-Fu(浓度均<50%半数致死浓度ID50的1/5)联合照射对鼻咽癌细胞系CNE-1的体外放射增敏作用。流式细胞仪分析加药后各时间段的细胞周期变化。Western blot分析5-Fu和FUDR处理后细胞p53蛋白表达变化。结果从浓度抑制率曲线得出FUDR和5-Fu的ID50分别为0.078和0.509 mg/mL;成克隆分析法得出FUDR的放射增敏比和放疗2 Gy时的增敏比分别为1.504和1.677;5-FU的放射增敏比和放疗2 Gy时的增敏比分别为1.159和1.287;加入FUDR或5-Fu后各时间段S期细胞较对照组均增多,加药12 h后各时间段的差异均有统计学意义(P<0.05),但两药比较无统计学差异。Western blot结果显示,应用FUDR和5-FU处理后CNE-1细胞系p53蛋白表达增加,FUDR组增加更明显。结论低浓度的FUDR和5-Fu分别联合放疗均能增加鼻咽癌细胞系CNE-1的放射敏感性,且FUDR的增敏作用强于5-Fu;FUDR和5-Fu作用于鼻咽癌CNE-1细胞系均增加p53蛋白表达,FUDR作用更明显。FUDR和5-Fu作用于CNE-1细胞系后未见细胞周期重新分布于放射敏感时相,且二者对细胞周期的影响无明显差异。 Objective To study the cytotoxicity of FUDR on nasopharyngeal carcinoma cell fine CNE-1 and evaluate the radiosensitivity of noncytotoxic FUDR,and compare the effieaey with 5-fluorouracil (5-Fu). Methods The concentration suppression rate curve was estab- lished by using cell counting kit 8, and IDs0 of FUDR and 5-Fu was calculated ; then the radiosensitization of low concentration of FUDR and 5-Fu (〈1/5 ID50) on nasopharyngeal carcinoma line CNE-1 associated with radiotherapy was determined by clonogenic assay. Cell cycle of different groups was determined by flow cytometry. The expression of p53 was measured by Western blot analysis in 5-Fu and FUDR treated cells. Results The ID50 of FUDR and 5-Fu were 0.078 mg/mL and 0.509 mg/mL respectively from concentration suppression rate curve. Cell survival experiments showed the sensitivity enhancement ratio (SER) and SER2 of FUDR were 1.504 and 1.677,which were 1.159 and 1.287 of 5-Fu.The proportion of cells in S phase increased after 6,12,18,24 hours exposure to both FUDR and 5-Fu. The expression of p53 was significantly increased after FUDR and 5-Fu treatment, especially in FUDR treated cells. Conclusion Noncytotoxie concentration FUDR has better radiosensitization effect on human nasopharyngeal carcinoma cell line CNE-1 than 5-Fu. The results of Western blot demon- strated that the expression of IO53 were increased in 5-Fu and FUDR treated CNE-1 cells,especially in FUDR group. The mdiosensitization is not related to the distribution of cell cycle and there was no statistical significance of the cell cycle distribution between FUDR and 5-Fu treated groups.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2012年第11期1022-1025,共4页 Journal of China Medical University
关键词 氟尿嘧啶脱氧核苷 鼻咽癌 成克隆分析 放射增敏 P53 细胞周期 fluorodeoxyuridine nasopharyngeal carcinoma clonogenie assay radiosensitization cell cycle
  • 相关文献

参考文献12

  • 1VanLarr J,Rustum YM,Ackland SP. Comparison of 5-Fluoro-25-Deoxyurine with 5-fluorouracil and their role in the treatment of col-orectal[j]. Eur J Cancer, 1998,34 (3):296-306.
  • 2丁立,马鸿飞.氟尿嘧啶脱氧核苷治疗肿瘤新进展[J].国外医学(肿瘤学分册),1999,26(4):206-208. 被引量:14
  • 3谢正德,申昆玲.重视儿童非肿瘤性EB病毒感染疾病的研究[J].首都医科大学学报,2010,31(2):213-216. 被引量:43
  • 4孔飞.氟脲嘧啶脱氧核苷加顺铂同期化疗配合放疗治疗中晚期鼻咽癌疗效观察[J].海南医学,2004,15(9):58-59. 被引量:2
  • 5Chen CM,Johnson M,Smith BJ. Azidothymidine enhances fluo-rodeoxyuridine-mediated radiosensitization [J]. Int J Radiat OncolBiol Phys,2010,76(3):905-913.
  • 6Ben-Josef E,Normolle D,Ensminger WD. Phase II trial of high-doseconformal radiation therapy with concurrent hepatic artery floxuri-dine for unresectable intrahepatic malignancies [J]. J Clin Oncol,2005,23(34):8739-8747.
  • 7Lawrence TS,Blockstock AW,McGinn C. The mechanism of actionof radiosensitization of conventional chemotherapeutic agents [J].Semin Rad Oncol,2003,13( 1) : 13-21.
  • 8Wilson GD,Bentzen SM,Harari PM. Biologic basis for combiningdrugs with radiation [J]. Semin Rad Oncol,2006 ’16(1): 2-9.
  • 9Ahsan A,Hiniker SM,Davis MA. The role of cell cycle in epidermalgrowth factor receptor inhibitor-mediated radiosensitization [ J ]. Can-cer Res,2009,69(12):5108-5114.
  • 10Mierzwa ML,Nyati MK,Morgan MA. Recent advances in combinedmodality therapy[j]. Oncologist,2010,15(4) :372-381.

二级参考文献16

  • 1申昆玲,段红梅.重症EB病毒感染相关疾病的现状和诊治进展[J].小儿急救医学,2005,12(5):341-344. 被引量:20
  • 2Giaccia AJ, Kastan MB. The complexity of p53 modulation: emerging patterns from divergent signals[J]. Genes Dev, 1998, 12 (19): 2973-83.
  • 3Murono, Yoshizaki, C-S Park. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma[J]. Histopathology, 1999, 34(5): 432-8.
  • 4Bouska A, Eischen CM. Murine double minute 2: p53-independent roads lead to genome instability or death[J]. Trends Biochem Sci, 2009, 34(6): 279-86.
  • 5Crook T, Nicholls JM, Brooks L, et al. High level expression of data-Np63:a mechanism for the inactivation of p53in undifferentiated nasopharyngeal carcinoma(NPC)[J]? Oncogene, 2000,1900): 3439-44.
  • 6Westfall MD, Mays D J, Sniezek JC, et al. The Delta-Np63 Alpha Phosphoprotein Binds the p21 and 14-3-3 Sigma Promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations [J]. Mol Cell Biol, 2003, 23 (7): 2264-76.
  • 7Ding L, Erdmann C, Chinnaiyan AM, et al. Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissue[J]. Cancer Res, 2006, 66(8): 4095-9.
  • 8Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer [J]. Nature, 2002, 419(6907): 572-3.
  • 9Raaphorst FM, Meijer C J, Fieret E, et al. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene [J]. Neoplasia, 2003, 5(6): 481-8.
  • 10Bracken AP, Pasini D, Capra M, et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer[J]. EMBO, 2003, 22(20): 5323-35.

共引文献65

同被引文献8

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部